BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
parmax pharma limited stock

Parmax Pharma Limited Share Price

47 2.00 (4.44%)
Dec 13 2024 02:48 PM Pharmaceuticals NSE: PARMAX

Parmax Pharma Limited Share Price Update

As of the latest trading session, Parmax Pharma Limited share price is currently at 47, which is up by 2.00 from its previous closing. Today, the stock has fluctuated between 44.10 and 47.25. Over the past year, Parmax Pharma Limited has achieved a return of 52.15 %. In the last month alone, the return has been -3.90 %. Read More...

Parmax Pharma Limited Performance

Day Range

Low44.10 High47.25
47.00

52 Week Range

Low 24.18 High 54.00
47.00

Parmax Pharma Limited Share Price

540359

PARMAX

img img img img
No Data Available

Open Price

44.10

Prev. Close

45.00

Volume (Shares)

1563.00

Total traded value

.72

Upper Circuit

47.25

Lower Circuit

42.75

Note: The current prices & values are delayed, Login to your account for live updates.

Parmax Pharma Limited Fundamentals


(Standalone)

Market Cap (Cr) 17.60
PE Ratio (TTM) -5.16
Book Value / Share -2.16
Beta 0.29
ROE 0.00%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -0.22

Parmax Pharma Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 9.28
Operating Expense 9.61
Net Profit -0.22
Net Profit Margin (%) -2.37
Earnings Per Share (EPS) -0.58
EBITDA 0.31
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 7.82
Operating Expense 7.81
Net Profit 0.01
Net Profit Margin (%) 0.12
Earnings Per Share (EPS) 0.03
EBITDA 0.52
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 4.26
Operating Expense 5.62
Net Profit -1.45
Net Profit Margin (%) -34.03
Earnings Per Share (EPS) -3.88
EBITDA -0.79
Effective Tax Rate (%) -6.61
Particulars DEC 2023 (Values in Cr)
Revenue 1.33
Operating Expense 3.09
Net Profit -1.75
Net Profit Margin (%) -131.57
Earnings Per Share (EPS) -4.68
EBITDA -1.14
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 4.07
Operating Expense 5.43
Net Profit -1.37
Net Profit Margin (%) -33.66
Earnings Per Share (EPS) -3.66
EBITDA -0.76
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 11.05
Operating Expense 16.76
Net Profit -5.75
Net Profit Margin (%) -52.03
Earnings Per Share (EPS) -15.37
EBITDA -3.33
Effective Tax Rate (%) -1.59
Particulars MAR 2023 (Values in Cr)
Revenue 15.42
Operating Expense 15.42
Net Profit -0.10
Net Profit Margin (%) -0.64
Earnings Per Share (EPS) -0.28
EBITDA 2.30
Effective Tax Rate (%) 299.99
Particulars MAR 2022 (Values in Cr)
Revenue 18.25
Operating Expense 18.01
Net Profit 0.14
Net Profit Margin (%) 0.76
Earnings Per Share (EPS) 0.38
EBITDA 2.62
Effective Tax Rate (%) 53.33
Particulars MAR 2021 (Values in Cr)
Revenue 26.20
Operating Expense 25.08
Net Profit 0.75
Net Profit Margin (%) 2.86
Earnings Per Share (EPS) 2.02
EBITDA 3.50
Effective Tax Rate (%) 37.19
Particulars MAR 2020 (Values in Cr)
Revenue 20.93
Operating Expense 20.30
Net Profit 0.43
Net Profit Margin (%) 2.05
Earnings Per Share (EPS) 1.15
EBITDA 1.87
Effective Tax Rate (%) 41.09
Particulars MAR 2024 (Values in Cr)
Book Value / Share 0.16
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.91
EBITDA Margin -30.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 13.16
ROE % -1.69
ROCE % 3.76
Total Debt to Total Equity 0.89
EBITDA Margin 14.85
Particulars MAR 2022 (Values in Cr)
Book Value / Share 13.39
ROE % 2.38
ROCE % 6.04
Total Debt to Total Equity 0.94
EBITDA Margin 14.41
Particulars MAR 2021 (Values in Cr)
Book Value / Share 13.07
ROE % 13.79
ROCE % 14.26
Total Debt to Total Equity 1.02
EBITDA Margin 13.44
Particulars MAR 2020 (Values in Cr)
Book Value / Share 11.38
ROE % 8.88
ROCE % 8.40
Total Debt to Total Equity 1.11
EBITDA Margin 8.93
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 15.33
Total Liabilities 15.33
Total Equity 0.07
Share Outstanding 5100800
Price to Book Ratio 178.00
Return on Assets (%) -37.69
Return on Capital (%) -96.68
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.40
Total Assets 17.61
Total Liabilities 17.61
Total Equity 5.85
Share Outstanding 44512
Price to Book Ratio 2.31
Return on Assets (%) -0.59
Return on Capital (%) -1.01
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.05
Total Assets 17.97
Total Liabilities 17.97
Total Equity 5.95
Share Outstanding 4451150
Price to Book Ratio 3.05
Return on Assets (%) 0.78
Return on Capital (%) 1.35
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.54
Total Assets 22.72
Total Liabilities 22.72
Total Equity 5.81
Share Outstanding 4451150
Price to Book Ratio 2.72
Return on Assets (%) 3.31
Return on Capital (%) 6.7
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.76
Total Assets 21.06
Total Liabilities 21.06
Total Equity 5.06
Share Outstanding 4451150
Price to Book Ratio 0.00
Return on Assets (%) 2.03
Return on Capital (%) 4.25
Particulars MAR 2024 (Values in Cr)
Net Income -5.65
Cash from Operations -0.19
Cash from Investing -1.58
Cash from Financing 1.42
Net change in Cash -0.34
Free Cash Flow 1.29
Particulars MAR 2023 (Values in Cr)
Net Income 0.04
Cash from Operations 0.33
Cash from Investing -0.93
Cash from Financing -0.04
Net change in Cash -0.64
Free Cash Flow 1.26
Particulars MAR 2022 (Values in Cr)
Net Income 0.30
Cash from Operations 0.74
Cash from Investing -1.53
Cash from Financing -0.91
Net change in Cash -1.69
Free Cash Flow 2.28
Particulars MAR 2021 (Values in Cr)
Net Income 1.20
Cash from Operations 3.52
Cash from Investing -3.14
Cash from Financing 0.39
Net change in Cash 0.77
Free Cash Flow 6.67
Particulars MAR 2020 (Values in Cr)
Net Income 0.73
Cash from Operations 2.82
Cash from Investing -2.39
Cash from Financing -0.22
Net change in Cash 0.20
Free Cash Flow 5.22
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 36.86 3.50 491.45 37.54 / 77.70
BLISS GVS PHARMA LTD 175.85 22.01 1.83 1852.87 92.25 / 179.65
CIPLA LTD 1447.35 25.32 4.12 116889.80 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 403.70 140.17 4.09 1188.13 145.00 / 440.00
GLAXOSMITHKLINE PHARMA LT 2254.45 47.63 22.83 38191.74 1668.20 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 55.77 10.90 491.45 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.90 45.61 7.28 2168.01 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6603.60 128.25 24.30 16509.00 4050.15 / 8139.85
BLISS GVS PHARMA LTD 175.85 22.93 1.80 1852.87 92.25 / 179.65

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 46.40
  • 26 Days 47.30
  • 10 Days 47.10
  • 50 Days 46.20
  • 12 Days 47.00
  • 100 Days 43.50
  • 20 Days 47.40
  • 200 Days 33.20
45.09
PIVOT
First Resistance 45.19
Second Resistance 45.37
Third Resistance 45.47
First Support 44.91
Second Support 44.81
Third Support 44.63
RSI 50.58
MACD -0.21
Commodity Channel Index (CCI) -56.12
ADX 16.15
Williams % R -45.57

Over 1 Month

down

-3.90

Over 3 Months

down

11.63

Over 6 Months

down

51.61

Over 1 Year

down

52.15

Over 3 Years

down

-3.92

Over 5 Years

down

19.98

Parmax Pharma Limited Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

Parmax Pharma Limited Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
69.19
Promoter Holdings
30.8
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Alkesh Mahasukh Gopani Shareholding of Promoter and Promoter Group 670380.0 17.92
Vipul Mahasukhlal Gopani Shareholding of Promoter and Promoter Group 481370.0 12.87
Gosalia Meena Alkesh Public Shareholding 474800.0 12.69
Pradeep Ramniklal Gosalia Public Shareholding 302714.0 8.09
Umang Alkesh Gosalia Public Shareholding 200000.0 5.35
Gosalia Nimit P Public Shareholding 90000.0 2.41
Bharti Deepak Mehta Public Shareholding 57466.0 1.54
Gosalia Vandana P Public Shareholding 40000.0 1.07
Pravina Mahasukhlal Gopani Shareholding of Promoter and Promoter Group 700.0 0.02
Mahasukhlal Gopani Shareholding of Promoter and Promoter Group 0.0 0.0

Parmax Pharma Limited

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About Parmax Pharma Limited

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by Parmax Pharma Limited

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Parmax Pharma Ltd?

Answer Field

The share price of Parmax Pharma Ltd for NSE is ₹ 0.00 and for BSE is ₹ 47.00.

What is the Market Cap of Parmax Pharma Ltd?

Answer Field

The market cap of Parmax Pharma Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 17.60 Cr. as of now.

What is the 52 Week High and Low of Parmax Pharma Ltd?

Answer Field

The 52 Week High and Low of Parmax Pharma Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 54.00 and ₹ 24.18.

How to Buy Parmax Pharma Ltd share?

Answer Field

You can trade in Parmax Pharma Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Parmax Pharma Ltd?

Answer Field

The 1 year returns on the stock has been 52.15%.

What is the Current Share Price of Parmax Pharma Ltd?

Answer Field

Parmax Pharma Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 47.00 as on Dec 13 2024 02:48 PM.

What is the Market Cap of Parmax Pharma Ltd Share?

Answer Field

The market cap of Parmax Pharma Ltd for NSE ₹ 0.0 & for BSE ₹ 17.60 as on Dec 13 2024 02:48 PM.

What is the P/E Ratio of Parmax Pharma Ltd Share?

Answer Field

As on Dec 13 2024 02:48 PM the price-to-earnings (PE) ratio for Parmax Pharma Ltd share is -5.16.

What is the PB ratio of Parmax Pharma Ltd Share?

Answer Field

As on Dec 13 2024 02:48 PM, the price-to-book (PB) ratio for Parmax Pharma Ltd share is -2.16.

How to Buy Parmax Pharma Ltd Share?

Answer Field

You can trade in Parmax Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Parmax Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Parmax Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Parmax Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader